Sinclair Lab Research ·
Nicotinamide supplementation improves healthspan in mice but does not extend lifespan. This study conducted by Prof. David Sinclair and colleagues at Harvard Medical School investigates the effects of nicotinamide (NAM), a precursor to NAD+, on healthspan metrics in mice. The findings contribute to the understanding of the NAD+/sirtuin axis and its implications for aging and longevity research.
What this study examined
The research focused on the impact of chronic nicotinamide supplementation on healthspan indicators in mice, particularly those on a high-fat diet (HFD). The study utilized untargeted metabolite profiling and metabolic flux analysis of liver-derived cells to assess changes in glucose homeostasis, hepatic steatosis, and inflammation. The primary outcome was the evaluation of healthspan improvements without any observed extension in lifespan.
Why this matters for longevity research
This study is significant as it highlights the distinction between healthspan and lifespan, a critical consideration in longevity research. While many interventions aim to extend lifespan, the ability to improve healthspan—defined as the period of life spent in good health—is crucial for enhancing quality of life in aging populations. The findings suggest that nicotinamide may play a beneficial role in mitigating metabolic dysfunction associated with aging, particularly in the context of high-fat diets.
Key findings
- Chronic nicotinamide supplementation improved healthspan measures in mice.
- No extension of lifespan was observed in the treated mice.
- Improvements in glucose homeostasis were noted in high-fat diet-fed mice.
- Reduced hepatic steatosis and inflammation were associated with NAM treatment.
- Increased glycogen deposition and metabolic flux through the pentose phosphate and glycolytic pathways were observed.
- The expression of NAM salvage pathways was depressed, countered by increased expression of de novo NAD biosynthetic enzymes.
- Acetylation of SIRT1 targets was enhanced in a diet- and NAM dose-dependent manner.
The science behind it
Nicotinamide is a precursor to NAD+, a crucial coenzyme involved in various metabolic processes and cellular functions. The NAD+/sirtuin axis is central to the regulation of cellular health and longevity. Sirtuins, a family of NAD+-dependent deacetylases, play a vital role in cellular stress resistance, metabolism, and aging. The study's findings suggest that while nicotinamide supplementation does not increase NAD+ levels, it may enhance the activity of sirtuins by increasing the acetylation of their targets, thereby improving metabolic health in mice.
How it fits into the longevity field
This research aligns with the broader literature exploring the role of NAD+ and its precursors in aging and longevity. Other interventions, such as caloric restriction and exercise, have also been shown to influence NAD+ levels and sirtuin activity. The findings regarding nicotinamide may inform future studies on dietary interventions and their potential to enhance healthspan without necessarily extending lifespan.
Practical takeaways
Researchers and informed readers should consider the implications of nicotinamide on healthspan, particularly in the context of metabolic health and aging. While the study does not support the notion of lifespan extension through NAM supplementation, it raises important questions about the potential for improving healthspan through dietary interventions. Further research is warranted to explore the mechanisms and effects of nicotinamide in various populations.
FAQ
What is nicotinamide?
Nicotinamide is a form of vitamin B3 that serves as a precursor to NAD+, an essential molecule for cellular metabolism and energy production.
Does nicotinamide extend lifespan?
This study found that while nicotinamide improved healthspan measures in mice, it did not extend their lifespan.
How does nicotinamide affect metabolic health?
Nicotinamide supplementation improved glucose homeostasis and reduced liver inflammation in mice on a high-fat diet, indicating potential benefits for metabolic health.
Source: PubMed · Cell Metab · published 2018-03-06.